Abstract
A letter to the editor to discuss several uses of brain magnetic resonance imaging (MRI) in the investigation of neurological manifestations of covid-19. Described several situations in which the MRI is needed. Brain MRI is an important diagnostic method in the covid-19 scenario, to investigate possible neurological complications of the disease.
CNS & Neurological Disorders - Drug Targets
Title:Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging
Volume: 20 Issue: 5
Author(s): Rubens J. Gagliardi*, Renan Domingues, Cristine Cukier, Maria F. Mendes, Vivian D.B. Gagliardi and Francisco T.M. de Oliveira
Affiliation:
- Department of Medicine, Santa Casa de Sao Paulo School of Medical Sciences, Discipline Neurology, Sao Paulo/SP,Brazil
Abstract: A letter to the editor to discuss several uses of brain magnetic resonance imaging (MRI) in the investigation of neurological manifestations of covid-19. Described several situations in which the MRI is needed. Brain MRI is an important diagnostic method in the covid-19 scenario, to investigate possible neurological complications of the disease.
Export Options
About this article
Cite this article as:
Gagliardi J. Rubens *, Domingues Renan , Cukier Cristine , Mendes F. Maria , Gagliardi D.B. Vivian and de Oliveira T.M. Francisco , Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging, CNS & Neurological Disorders - Drug Targets 2021; 20 (5) . https://dx.doi.org/10.2174/1871527320666210122093458
DOI https://dx.doi.org/10.2174/1871527320666210122093458 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Base Distribution in Dengue Nucleotide Sequences Differs Significantly from Other Mosquito-Borne Human-Infecting Flavivirus Members
Current Computer-Aided Drug Design Neuro-AIDS: Current Status and Challenges to Antiretroviral Drug Therapy (ART) for Its Treatment
Current Drug Therapy Therapeutic Targets in Respiratory Viral Infections
Current Medicinal Chemistry The Aging of the Adaptive Immune System
Current Immunology Reviews (Discontinued) Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research Proinflammatory Cytokines and Chemokines in Neonatal Brain Damage
Current Pediatric Reviews Dengue Virus Entry/Fusion Inhibition By Small Bioactive Molecules: A Critical Review
Mini-Reviews in Medicinal Chemistry In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Current Medicinal Chemistry - Central Nervous System Agents Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Current Pharmaceutical Biotechnology Epigenetic Drugs for Multiple Sclerosis
Current Neuropharmacology Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Current Pharmaceutical Design The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs
Current Molecular Medicine Countermeasures to the Bioterrorist Threat of Smallpox
Current Molecular Medicine The Role of Microglial Cells on Neuroinflammation: Possible Therapeutic Applications
Recent Patents on Regenerative Medicine Leptin and Interleukin-1β Modulate Neuronal Glutamate Release and Protect Against Glucose-Oxygen-Serum Deprivation
Current Neurovascular Research An Update on the Roles of the Complement System in Autoimmune Diseases and the Therapeutic Possibilities of Anti-Complement Agents
Current Drug Therapy Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology
Current Pediatric Reviews